PixelPin secures 1-5m funding to advance image-based authentication
By Nikita Chaurasia  Date: 2019-04-13

PixelPin secures 1-5m funding to advance image-based authentication

The new funds will be used to target new customers in the retail and finance sectors, as well as support continued product development

PixelPin, a UK-based startup, has reportedly secured a £1.5m pre-Series A round of funding for its image-based authentication technology that replaces passwords with pictures.

Sources with knowledge on the matter informed that the investment round was led by SBI Investment, subsidiary of SBI Holdings previously known as Softbank Investment. SBI Investment poured in £1m from the SBI AI and Blockchain Fund, while additional investment of £500k was received from present Angel investors, bringing it to total of £1.5m.

Seemingly, PixelPin is FIDO-certified and will utilize its new funds to target new customers in the retail and finance sectors, as well as support continued product development. Along with this, the funding is being utilized to set up new offices in Tokyo to act as a base for the company’s expansion into Japan and the broader Asian market.

Sources said that the cloud-based platform of the PixelPin, which is hosted on Microsoft Azure, replaces PINs and passwords for a personal, user-friendly and highly secure means of logging into online accounts for shopping, banking and other uses.

Instead of memorizing pins or passwords users can choose a picture and four precise points on that picture that must be chosen in sequence for logging into their online accounts.

Reportedly, the platform of PixelPin has a remarkable success rate, as it takes on an average just 10 seconds for a user to login and one minute to register. It has a 92% login success rate which is three times higher than passwords (30%).

The solution from PixelPin generates a highly personalized and easy-to-use login experience that will be mainly popular with a tech-savvy younger generation, sources commented. The platform performs without compromising on security and is also recognized as more secure than using passwords.

After this round of funding, PixelPin’ boasts of $4.5 million in total funding received till date, which has facilitated its development globally with partnerships across Europe, Americas, and Asia.

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...